ArticlePharmaceuticals (Basel, Switzerland)2023

Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation.

Marina Saresella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.